NCT04357184

Brief Summary

Muscle weakness or atrophy is a common condition following acute and chronic musculoskeletal injuries. Strength training is an imperative component in clinical rehabilitation of musculoskeletal injuries. Heavy exercise loads (approximately 70% of one repetition maximum) is necessary to elicit muscle hypertrophy and strength gains. However, patients with severe muscle atrophy are frequently unable to tolerate these loads due to pain. Blood flow resistance training with low resistance loads may be used to safely develop muscle strength.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 14, 2020

Completed
Same day until next milestone

Study Start

First participant enrolled

April 14, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 22, 2020

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 15, 2022

Completed
Last Updated

February 16, 2022

Status Verified

February 1, 2022

Enrollment Period

1.8 years

First QC Date

April 14, 2020

Last Update Submit

February 15, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Isometric quadriceps and hamstrings muscle strength

    Isometric knee flexor and extensor strength will be measured with an isokinetic dynamometer before training and after each series of 9 training sessions

    Strength will be measured for each patient before training begins and then after 9 training sessions have been completed, for the duration of the study, up to 100 weeks

Secondary Outcomes (1)

  • Patient rating

    The intensity of muscle burn will be determined during each training session. The overall satisfaction will be determined after the last training session for each patient, for the duration of the study, up to 100 weeks.

Study Arms (1)

BFRT with 4 exercises and low resistance loads

EXPERIMENTAL

Blood flow resistance training will be performed with a standard blood pressure cuff that is placed and inflated by a clinician. The patient will perform 4 exercises with low resistance loads that will produce a muscle burn to enhance promotion of strength. Training will be supervised in the clinic. The cuff is deflated between exercises.

Other: Blood flow restriction training

Interventions

BFRT is done with 4 exercises with low load resistance of 30% 1 repetition maximum

BFRT with 4 exercises and low resistance loads

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with \> 20% deficit in isometric quadriceps and/or hamstrings strength
  • Patients willing to complete at least 9 BFRT training sessions
  • Patients willing to provide informed consent (or parental consent)

You may not qualify if:

  • Pregnancy
  • History of varicose veins
  • History of blood clots or active blood clot
  • Taking oral contraceptives
  • History of heart attack
  • Unstable cardiac disease
  • Taking heart failure medication
  • Uncontrolled hypertension (\> 140/90)
  • Uncontrolled tachycardia (\> 100 bpm)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cincinnati Sportsmedicine and Orthopaedic Center

Cincinnati, Ohio, 45242, United States

Location

MeSH Terms

Conditions

Muscular AtrophyMuscle Weakness

Interventions

Blood Flow Restriction Therapy

Condition Hierarchy (Ancestors)

Neuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and SymptomsMuscular DiseasesMusculoskeletal DiseasesPathologic Processes

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Study Officials

  • Frank R Noyes, MD

    Cincinnati Sportsmedicine Research and Education Foundation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director Clinical Studies

Study Record Dates

First Submitted

April 14, 2020

First Posted

April 22, 2020

Study Start

April 14, 2020

Primary Completion

February 15, 2022

Study Completion

February 15, 2022

Last Updated

February 16, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations